BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 30111747)

  • 1. Molecular Signatures of the Insulin-like Growth Factor 1-mediated Epithelial-Mesenchymal Transition in Breast, Lung and Gastric Cancers.
    Cevenini A; Orrù S; Mancini A; Alfieri A; Buono P; Imperlini E
    Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30111747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The involvement of survivin in insulin-like growth factor 1-induced epithelial-mesenchymal transition in gastric cancer.
    Li C; Li J; Wu D; Han G
    Tumour Biol; 2016 Jan; 37(1):1091-6. PubMed ID: 26271669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factors are essential to prevent anoikis in oestrogen-responsive breast cancer cells: importance of the type I IGF receptor and PI3-kinase/Akt pathway.
    Luey BC; May FE
    Mol Cancer; 2016 Jan; 15():8. PubMed ID: 26801096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer-associated fibroblasts promote epithelial-mesenchymal transition and EGFR-TKI resistance of non-small cell lung cancers via HGF/IGF-1/ANXA2 signaling.
    Yi Y; Zeng S; Wang Z; Wu M; Ma Y; Ye X; Zhang B; Liu H
    Biochim Biophys Acta Mol Basis Dis; 2018 Mar; 1864(3):793-803. PubMed ID: 29253515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IGF-I induces upregulation of DDR1 collagen receptor in breast cancer cells by suppressing MIR-199a-5p through the PI3K/AKT pathway.
    Matà R; Palladino C; Nicolosi ML; Lo Presti AR; Malaguarnera R; Ragusa M; Sciortino D; Morrione A; Maggiolini M; Vella V; Belfiore A
    Oncotarget; 2016 Feb; 7(7):7683-700. PubMed ID: 26655502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibulin-3-mediated inhibition of epithelial-to-mesenchymal transition and self-renewal of ALDH+ lung cancer stem cells through IGF1R signaling.
    Kim IG; Kim SY; Choi SI; Lee JH; Kim KC; Cho EW
    Oncogene; 2014 Jul; 33(30):3908-17. PubMed ID: 24013232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of IGF/IGF-IR signaling pathway fails to induce epithelial-mesenchymal transition in pancreatic cancer cells.
    Kopantzev EP; Kopantseva MR; Grankina EV; Mikaelyan A; Egorov VI; Sverdlov ED
    Pancreatology; 2019 Mar; 19(2):390-396. PubMed ID: 30799278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Autocrine IL-6/IGF-1R Loop Mediates EMT and Promotes Tumor Growth in Non-small Cell Lung Cancer.
    Zheng X; Lu G; Yao Y; Gu W
    Int J Biol Sci; 2019; 15(9):1882-1891. PubMed ID: 31523190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with insulin-like growth factor 1 receptor inhibitor reverses hypoxia-induced epithelial-mesenchymal transition in non-small cell lung cancer.
    Nurwidya F; Takahashi F; Kobayashi I; Murakami A; Kato M; Minakata K; Nara T; Hashimoto M; Yagishita S; Baskoro H; Hidayat M; Shimada N; Takahashi K
    Biochem Biophys Res Commun; 2014 Dec; 455(3-4):332-8. PubMed ID: 25446090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osthole inhibits insulin-like growth factor-1-induced epithelial to mesenchymal transition via the inhibition of PI3K/Akt signaling pathway in human brain cancer cells.
    Lin YC; Lin JC; Hung CM; Chen Y; Liu LC; Chang TC; Kao JY; Ho CT; Way TD
    J Agric Food Chem; 2014 Jun; 62(22):5061-71. PubMed ID: 24828835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ginkgoic acid impedes gastric cancer cell proliferation, migration and EMT through inhibiting the SUMOylation of IGF-1R.
    Liu D; Li Z; Yang Z; Ma J; Mai S
    Chem Biol Interact; 2021 Mar; 337():109394. PubMed ID: 33508304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor-1 activates different catalytic subunits p110 of PI3K in a cell-type-dependent manner to induce lipogenesis-dependent epithelial-mesenchymal transition through the regulation of ADAM10 and ADAM17.
    Park GB; Kim D
    Mol Cell Biochem; 2018 Feb; 439(1-2):199-211. PubMed ID: 28819788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IGF1/IGF1R/STAT3 signaling-inducible IFITM2 promotes gastric cancer growth and metastasis.
    Xu L; Zhou R; Yuan L; Wang S; Li X; Ma H; Zhou M; Pan C; Zhang J; Huang N; Shi M; Bin J; Liao Y; Liao W
    Cancer Lett; 2017 May; 393():76-85. PubMed ID: 28223169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GIPC mediates the generation of reactive oxygen species and the regulation of cancer cell proliferation by insulin-like growth factor-1/IGF-1R signaling.
    Choi JS; Paek AR; Kim SY; You HJ
    Cancer Lett; 2010 Aug; 294(2):254-63. PubMed ID: 20206441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The insulin-like growth factor-I receptor (IGF-IR) in breast cancer: biology and treatment strategies.
    Motallebnezhad M; Aghebati-Maleki L; Jadidi-Niaragh F; Nickho H; Samadi-Kafil H; Shamsasenjan K; Yousefi M
    Tumour Biol; 2016 Sep; 37(9):11711-11721. PubMed ID: 27444280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Src promotes EGF-induced epithelial-to-mesenchymal transition and migration in gastric cancer cells by upregulating ZEB1 and ZEB2 through AKT.
    Zhao L; Li X; Song N; Li A; Hou K; Qu X; Che X; Liu Y
    Cell Biol Int; 2018 Mar; 42(3):294-302. PubMed ID: 29052277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IGF-1-induced epithelial-mesenchymal transition in MCF-7 cells is mediated by MUC1.
    Liao G; Wang M; Ou Y; Zhao Y
    Cell Signal; 2014 Oct; 26(10):2131-7. PubMed ID: 24971507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leptin promotes epithelial-mesenchymal transition of breast cancer via the upregulation of pyruvate kinase M2.
    Wei L; Li K; Pang X; Guo B; Su M; Huang Y; Wang N; Ji F; Zhong C; Yang J; Zhang Z; Jiang Y; Liu Y; Chen T
    J Exp Clin Cancer Res; 2016 Oct; 35(1):166. PubMed ID: 27769315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IGF-1 contributes to the expansion of melanoma-initiating cells through an epithelial-mesenchymal transition process.
    Le Coz V; Zhu C; Devocelle A; Vazquez A; Boucheix C; Azzi S; Gallerne C; Eid P; Lecourt S; Giron-Michel J
    Oncotarget; 2016 Dec; 7(50):82511-82527. PubMed ID: 27764776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergy between an IGF-1R antibody and Raf/MEK/ERK and PI3K/Akt/mTOR pathway inhibitors in suppressing IGF-1R-mediated growth in hematopoietic cells.
    Bertrand FE; Steelman LS; Chappell WH; Abrams SL; Shelton JG; White ER; Ludwig DL; McCubrey JA
    Leukemia; 2006 Jul; 20(7):1254-60. PubMed ID: 16642049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.